Clinical Trials Logo

Clinical Trial Summary

The BACILO study was designed with the objective of having robust data on local epidemiological bacterial colonisation information on bile cultures with patients taken to laparoscopic cholecystectomy in our institution to find which predictive factors are associated with culture positivity and antibiotic resistance patterns. Secondary endpoints include evaluating demographical, clinical and surgical variables and establishing comparison between both positive and negative bile cultures and between antibiotic sensitive and resistant microorganism strain isolations.


Clinical Trial Description

BACILO is single-centre, observational, analytical, prospective study with a prognostic prediction model with the objective of identifying predictive factors associated with microbial and antibiotic resistance patterns in bile cultures of patients taken to laparoscopic cholecystectomy in our institution. Primary outcomes are bile culture positivity and phenotypical resistance antibiogram patterns while secondary outcomes include demographic, clinical and surgical characteristics and surgical outcomes. The main objective is to determine predictive factors using a prediction model, variables included are: Age, diabetes mellitus, C-reactive protein test, choledocholithiasis/ERCP, cholecystitis and severity of cholecystitis according to the 2018 Tokyo guidelines.This in the nature of describing the relationship between bile culture positivity and phenotypical antibiogram resistance patterns in our institution, and establish thus better treatment strategies based on higher quality local evidence. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06314399
Study type Observational
Source Hospital Universitario Mayor Méderi
Contact
Status Not yet recruiting
Phase
Start date April 1, 2024
Completion date June 2026

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06262009 - Dynamics of AMR Spread, Persistence and Evolution Between Humans, Animals and Their Environment
Completed NCT04212403 - Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) N/A
Recruiting NCT04460313 - Nasopharyngeal Carriage of S. Pneumoniae N/A
Active, not recruiting NCT03208725 - Childhood Acute Illness and Nutrition Network
Completed NCT03963297 - Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination
Active, not recruiting NCT05027893 - Complications After Lower Third Molar Surgery N/A
Completed NCT05551988 - Predictors of Foot Amputation in Diabetic Foot Ulcers
Not yet recruiting NCT04795518 - The Pattern of Antibiotic Prescription for Children Among a Group of Pediatric Dentists.
Recruiting NCT03767283 - Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae
Completed NCT03061097 - Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization Phase 1
Withdrawn NCT03391674 - Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization N/A
Recruiting NCT04107194 - Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. Phase 3
Completed NCT03884348 - Tailored H. Pylori Eradication Based on Clarithromycin Resistance
Completed NCT04926935 - Bloodstram Infections in ICU. Single Centre Observational Study.
Not yet recruiting NCT04269174 - The Utility of Biofire Filmarray in Evaluation of Entero Pathogens Triggers in Patients With Chronic Diarrhea
Completed NCT03167398 - Fecal Microbiota Transplantation for Eradication of CRE Phase 1/Phase 2
Completed NCT03866291 - ESBL in Patients Returning to Sweden With Traveller's Diarrhoea
Completed NCT01902589 - Resistance of Helicobacter Pylori to Antibiotics in Children N/A
Not yet recruiting NCT04593368 - Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT) Phase 2
Completed NCT03063437 - A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization Phase 2